Nova Eye Medical
ASX:NOVAFremont, United States· Est.
Innovative medtech company delivering minimally invasive glaucoma surgery devices worldwide.
Is this your company? Claim your profile to update info and connect with investors.
Claim profileAI Company Overview
Innovative medtech company delivering minimally invasive glaucoma surgery devices worldwide.
OphthalmologyGlaucoma
Technology Platform
iTrack™ microcatheter canaloplasty and Molteno3® glaucoma drainage device, enabling minimally invasive fluid infusion, viscodilation, and drainage without stent implantation.
Opportunities
Expanding adoption of minimally invasive glaucoma surgery worldwide and leveraging FDA/CE cleared devices to enter new markets and indications.
Risk Factors
Regulatory changes, reimbursement challenges, and strong competition from established MIGS device manufacturers.
Competitive Landscape
Competes with iStent, Hydrus, Trabectome, and other MIGS platforms; differentiates through stent‑free canaloplasty and hand‑crafted microcatheter precision.